Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Beijing Northland Biotech. Co., Ltd.

Clinical trials sponsored by Beijing Northland Biotech. Co., Ltd., explained in plain language.

Not yet recruiting 1

New drug aims to shrink heart attack scar in major trial

Disease control Not yet recruiting

This study tests whether an investigational drug called NL005 can reduce permanent heart muscle damage in people who have had a severe heart attack (STEMI) and undergone emergency artery-opening treatment. About 189 participants will receive either a low dose, high dose, or place…

Phase: PHASE2 • Sponsor: Beijing Northland Biotech. Co., Ltd. • Aim: Disease control

Last updated May 26, 2026 10:51 UTC